Displaying items 73-84 of 147
» View wsbt.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-13
•
Next >
-
Women on the Pill have less menstrual pain
ReutersNEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds. Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...Tags: Menstruation, Birth Control, Ibuprofen (drug), Back Pain, Drugs and Medicines
-
Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline
Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...Tags: Diabetes, Chemical Industry, Anthrax, Science, Economy, Business and Finance
-
SEC accuses Stiefel Laboratories of defrauding employee shareholders
Money & CompanyThe Securities and Exchange Commission has accused Stiefel Laboratories, a subsidiary of GlaxoSmithKline, and the subsidiary’s former chief executive of defrauding employees and other shareholders by buying back the company’s private stock... -
Health care non-profits invited to bid for bucks
HealthDoes your health care non-profit have an impact on the community? GlaxoSmithKline wants to know. The pharmaceutical company is holding its 16th annual IMPACT awards to recognize community-based nonprofits that provide access to healthcare for the... -
The Morning Fix: '21 Jump Street' cleans up! O'Donnell hits road.
Company Town21 Jump Street finishes on top of the box office. James Murdoch exits another board. Rosie O'Donnell hits the road.... -
IUDs almost halve risk of cervical cancer: study
ReutersLONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...Tags: Immune System, Diseases and Illnesses, Birth Control, Health Organizations, Viral Diseases and Infections
-
Cancer study boosts hopes for Roche's armed antibody
ReutersSTOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...Tags: Breast Cancer, Diseases and Illnesses, Hair Loss, Biotechnology, Herceptin (drug)
-
Drug companies pay $25 million to Illinois doctors
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
Doctors in the...Tags: Gainesville, Chicago, Cephalon Incorporated, Health and Medical Professionals, Medical Procedures and Tests
-
Tailored breast cancer drugs in focus at cancer meet
ReutersZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...Tags: Breast Cancer, Diseases and Illnesses, Bevacizumab (drug), Human Body, Biotechnology
-
Study: At-home cervical cancer test could save thousands
A do-it-yourself test for cervical cancer could help prevent thousands of cases of the disease in women who don't have easy or regular access to smear tests, scientists said Wednesday. The DIY test, which detects the human papillomavirus (HPV)...Tags: Diseases and Illnesses, Preventative Medicine, University of Washington, Medical Procedures and Tests, Mexico
-
UK switches to Merck's Gardasil for HPV vaccination
ReutersLONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...Tags: Diseases and Illnesses, Preventative Medicine, Chemical Industry, London (England), United Kingdom
Jan 10, 2012
|Story| CNN
Jan 23, 2012
|Story| Reuters
Apr 19, 2012
|Story| Baltimore Sun
Dec 12, 2011
| Los Angeles Times
Mar 6, 2012
| Allentown Morning Call
Mar 19, 2012
| Los Angeles Times
Sep 13, 2011
|Story| Reuters
Sep 25, 2011
|Story| Reuters
Sep 27, 2011
|Story| Chicago Tribune
Sep 20, 2011
|Story| Reuters
Nov 2, 2011
|Story| Reuters
Nov 24, 2011
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.